Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Almirall, a pharmaceutical company, has entered into a three-year research alliance with BioFocus, an affiliate from Galapagos.
Subscribe to our email newsletter
The agreement is aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall.
As per the collaboration, BioFocus will apply its integrated drug discovery capabilities whilst Almirall will bring in respiratory specific knowhow to the joint experimental effort.
The value of this collaboration to BioFocus is expected to reach E7.5m.
Almirall R&D executive director Bertil Lindmark said that they selected BioFocus for this alliance because of the excellent technology and scientific fit between both the companies.